We are live on
!
Find out more
Rani Therapeutics
RANI
RANI
74 hedge funds and large institutions have $31.3M invested in Rani Therapeutics in 2026 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 16 increasing their positions, 14 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
9,917% more call options, than puts
Call options by funds: $3.51M | Put options by funds: $35K
138% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 8
16% more funds holding
Funds holding: 64 → 74 (+10)
14% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 14
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3.09% less ownership
Funds ownership: 45.95% → 42.86% (-3.1%)
48% less capital invested
Capital invested by funds: $60.5M → $31.3M (-$29.2M)
Holders
74
Holders Change
+10
Holders Change %
+15.63%
% of All Funds
0.91%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
19
Increased
16
Reduced
14
Closed
8
Calls
$3.51M
Puts
$35K
Net Calls
+$3.47M
Net Calls Change
-$8.89M
Top Buyers
| 1 |
Millennium Management
New York
|
+$310K |
| 2 |
LP
Longaeva Partners
Chicago,
Illinois
|
+$276K |
| 3 |
Jane Street
New York
|
+$212K |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$196K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$168K |
Top Sellers
| 1 |
SCP
SymBiosis Capital Partners
Bentonville,
Arkansas
|
-$3.36M |
| 2 |
Squarepoint
New York
|
-$419K |
| 3 |
Goldman Sachs
New York
|
-$350K |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$129K |
| 5 |
VF
Virtu Financial
New York
|
-$69K |
